- Home
- FIP vs IOVA Comparison
FIP vs IOVA Comparison
Compare FIP & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIP
- IOVA
- Stock Information
- Founded
- FIP 2021
- IOVA 2007
- Country
- FIP United States
- IOVA United States
- Employees
- FIP N/A
- IOVA N/A
- Industry
- FIP Consumer Electronics/Appliances
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FIP Industrials
- IOVA Health Care
- Exchange
- FIP Nasdaq
- IOVA Nasdaq
- Market Cap
- FIP 822.8M
- IOVA 975.1M
- IPO Year
- FIP N/A
- IOVA N/A
- Fundamental
- Price
- FIP $4.73
- IOVA $2.22
- Analyst Decision
- FIP Buy
- IOVA Buy
- Analyst Count
- FIP 1
- IOVA 11
- Target Price
- FIP $12.00
- IOVA $11.90
- AVG Volume (30 Days)
- FIP 3.5M
- IOVA 14.9M
- Earning Date
- FIP 08-07-2025
- IOVA 08-07-2025
- Dividend Yield
- FIP 2.54%
- IOVA N/A
- EPS Growth
- FIP N/A
- IOVA N/A
- EPS
- FIP N/A
- IOVA N/A
- Revenue
- FIP $382,522,000.00
- IOVA $241,525,000.00
- Revenue This Year
- FIP $60.89
- IOVA $67.40
- Revenue Next Year
- FIP $36.62
- IOVA $56.32
- P/E Ratio
- FIP N/A
- IOVA N/A
- Revenue Growth
- FIP 16.07
- IOVA 636.99
- 52 Week Low
- FIP $3.10
- IOVA $1.64
- 52 Week High
- FIP $9.99
- IOVA $12.51
- Technical
- Relative Strength Index (RSI)
- FIP 39.61
- IOVA 43.38
- Support Level
- FIP $4.39
- IOVA $2.21
- Resistance Level
- FIP $5.51
- IOVA $2.76
- Average True Range (ATR)
- FIP 0.32
- IOVA 0.21
- MACD
- FIP 0.03
- IOVA -0.04
- Stochastic Oscillator
- FIP 36.44
- IOVA 26.19
About FIP FTAI Infrastructure Inc.
FTAI Infrastructure Inc is engaged in five segments; Railroad segment includes five freight railroads and one switching company that provide rail service to certain manufacturing and production facilities, the Jefferson Terminal segment consists of a multi-modal crude oil and refined products terminal and other related assets. Repauno segment consists of a 1,630-acre deep-water port located along the Delaware River with an underground storage cavern, a new multipurpose dock, a rail-to-ship transloading system, and multiple industrial development opportunities. Power and Gas segment is comprised of an equity method investment in Long Ridge, and Sustainability and Energy Transition segment is comprised of Aleon/Gladieux, Clean Planet, and CarbonFree.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.